Clinical trial
Drug Use Surveillance for Cabometyx Tablets "Renal Cell Carcinoma"
NCT04804813 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Use Surveillance for Cabometyx Tablets "Renal Cell Carcinoma"
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 29, 2021
- Completion date
- July 25, 2024
- Enrollment
- 388 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma